학술논문

Coronary artery stenosis in Japanese people living with HIV-1 with or without haemophilia.
Document Type
Academic Journal
Author
Nagai R; Department of Cardiology, National Centre for Global Health and Medicine, Tokyo, Japan.; Ogata M; AIDS Clinical Centre, National Centre for Global Health and Medicine, Tokyo, Japan.; Kubota S; Department of Cardiology, National Centre for Global Health and Medicine, Tokyo, Japan.; Yamamoto M; Department of Cardiology, National Centre for Global Health and Medicine, Tokyo, Japan.; Uemura H; AIDS Clinical Centre, National Centre for Global Health and Medicine, Tokyo, Japan.; Tanuma J; AIDS Clinical Centre, National Centre for Global Health and Medicine, Tokyo, Japan.; Gatanaga H; AIDS Clinical Centre, National Centre for Global Health and Medicine, Tokyo, Japan.; Hara H; Department of Cardiology, National Centre for Global Health and Medicine, Tokyo, Japan.; Oka S; AIDS Clinical Centre, National Centre for Global Health and Medicine, Tokyo, Japan.; Hiroi Y; Department of Cardiology, National Centre for Global Health and Medicine, Tokyo, Japan.
Source
Publisher: National Center for Global Health and Medicine Country of Publication: Japan NLM ID: 101771579 Publication Model: Print Cited Medium: Internet ISSN: 2434-9194 (Electronic) Linking ISSN: 24349186 NLM ISO Abbreviation: Glob Health Med Subsets: PubMed not MEDLINE
Subject
Language
English
Abstract
An extremely high prevalence (12.2%) of moderate-to-severe coronary artery stenosis (CAS) was documented in asymptomatic Japanese haemophiliacs living with HIV-1 (JHLH) in our previous study. The cause of this phenomenon remains unknown. We conducted the CAS screening in people living with HIV-1 without haemophilia (PLWH without haemophilia) to compare the prevalence of CAS in JHLH and PLWH without haemophilia and to identify the risk factors including inflammation markers. Ninety-seven age-matched male PLWH without haemophilia who consulted our outpatient clinic between June and July 2021 were randomly selected, and 69 patients who provided informed consent were screened for CAS using coronary computed tomography angiography (CCTA). The number of JHLH cases was 62 in this study. The prevalence of moderate (> 50%) to severe (> 75%) CAS was significantly higher in JHLH [14/57 (24.6%) vs. 6/69 (8.7%), p = 0.015], and the ratio of CAS requiring urgent interventions was significantly higher [7 (12.3%) vs. 1 (1.4%), p = 0.013] in JHLH than in PLWH without haemophilia. Among the inflammatory markers, serum titres of intercellular adhesion molecule-1 ( p < 0.05) and interleukin-6 ( p < 0.05) in JHLH were significantly higher than those in PLWH without haemophilia. Although some patient demographics were different in the age-matched study, it might be possible to speculate that intravascular inflammation might promote CAS in JHLH.
Competing Interests: The authors have no conflicts of interest to disclose.
(2024, National Center for Global Health and Medicine.)